ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Overview Fund Activity
Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

62 hedge funds and large institutions have $755M invested in Orchard Therapeutics plc American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 18 closing their positions.

Holders
62
Holders Change
-6
Holders Change %
-8.82%
% of All Funds
1.36%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
13
Increased
26
Reduced
10
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$39.9M
2
Federated Hermes
2
Federated Hermes
Pennsylvania
$12.5M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$58.9M
4
Citadel Advisors
4
Citadel Advisors
Florida
$7.67M
5
FCMI
5
Foresite Capital Management IV
California
$6.63M

Top Sellers

1
VC
1
Vivo Capital
California
$0
2
VMI
2
VHCP Management III
New York
$0
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$0
4
MIM
4
Monashee Investment Management
Massachusetts
$0
5
PI
5
Putnam Investments
Massachusetts
$11.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
LI
76
Leap Investments
Illinois
– -$171K -1,220 Closed
LA
77
Legacy Advisors
Pennsylvania
– -$41K -295 Closed
TRCT
78
Tower Research Capital (TRC)
New York
– -$21K -149 Closed
Deutsche Bank
79
Deutsche Bank
Germany
– -$5K -40 Closed
1 2 3
4